Mount Sinai Health System: FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative Colitis

Press/Media

Period27 Oct 2023

Media coverage

1

Media coverage

  • TitleMount Sinai Health System: FDA Approves Mirikizumab, a Promising Induction and Maintenance Therapy for Ulcerative Colitis
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date27/10/23
    PersonsBruce E. Sands